Skip to main content
Erschienen in: Medical Oncology 1/2013

01.03.2013 | Original Paper

miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer

verfasst von: Bi-Lan Li, Cong Lu, Wen Lu, Ting-ting Yang, Junjie Qu, Xiayu Hong, Xiao-ping Wan

Erschienen in: Medical Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Endometrial cancer (EC) is the most common gynecologic malignancy, but the molecular events involved in the development and progression of EC remain unclear. Certain microRNAs (miRNAs) and DICER1 play important roles in cell motility and survival. This study investigated the role of miR-130b and DICER1 in EC. We profiled miR-130b and DICER1 expression in clinical samples explored its relationship with clinical parameters. A luciferase reporter assay assessed the miR-130b targeting potential of DICER1. We show both in vitro and in vivo that miR-130b overexpression along with DICER1 dysfunction leads to tumor aggression and miRNA synthesis abnormalities that are related to cancer hallmarks through DICER1–miRNAs axis modulation. We also identify the mechanism related to this potential tumor predisposing phenotype: miR-130b and loss of DICER1 induced abnormal expression of EMT-related genes, which constitutes a loop regulation of the miR-130b–DICER1–EMT axis.
Literatur
1.
Zurück zum Zitat Azueta A, Gatius S, Matias-Guiu X. Endometrioid carcinoma of the endometrium: pathologic and molecular features. Semin Diagn Pathol. 2010;27:226–40.PubMedCrossRef Azueta A, Gatius S, Matias-Guiu X. Endometrioid carcinoma of the endometrium: pathologic and molecular features. Semin Diagn Pathol. 2010;27:226–40.PubMedCrossRef
2.
Zurück zum Zitat Dedes KJ, Wetterskog D, Ashworth A, Kaye SB, Reis-Filho JS. Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol. 2011;8:261–71.PubMedCrossRef Dedes KJ, Wetterskog D, Ashworth A, Kaye SB, Reis-Filho JS. Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol. 2011;8:261–71.PubMedCrossRef
3.
Zurück zum Zitat Chaudhry P, Asselin E. Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer. 2009;16:363–80.PubMedCrossRef Chaudhry P, Asselin E. Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer. 2009;16:363–80.PubMedCrossRef
4.
Zurück zum Zitat Hammond SM. Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett. 2005;579:5822–9.PubMedCrossRef Hammond SM. Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett. 2005;579:5822–9.PubMedCrossRef
5.
Zurück zum Zitat Karube Y, Tanaka H, Osada H, et al. Reduced expression of DICER1 associated with poor prognosis in lung cancer patients. Cancer Sci. 2005;96:111–5.PubMedCrossRef Karube Y, Tanaka H, Osada H, et al. Reduced expression of DICER1 associated with poor prognosis in lung cancer patients. Cancer Sci. 2005;96:111–5.PubMedCrossRef
6.
7.
Zurück zum Zitat Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J, Kirsch DG, Golub TR, Jacks T. Dicer1 functions as a haploinsufficient tumosuppressor. Genes Dev. 2009;23:2700–4.PubMedCrossRef Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J, Kirsch DG, Golub TR, Jacks T. Dicer1 functions as a haploinsufficient tumosuppressor. Genes Dev. 2009;23:2700–4.PubMedCrossRef
8.
Zurück zum Zitat Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–66.PubMedCrossRef Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–66.PubMedCrossRef
9.
Zurück zum Zitat Yang C, Cai J, Wang Q, Tang H, Cao J, Liying W, Wang Z. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. Gynecol Oncol. 2012;124:325–34.PubMedCrossRef Yang C, Cai J, Wang Q, Tang H, Cao J, Liying W, Wang Z. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. Gynecol Oncol. 2012;124:325–34.PubMedCrossRef
10.
Zurück zum Zitat Abu-Rustum NR, Zhou Q, Iasonos A, Alektiar KM, et al. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer. 2010;21:511–6.CrossRef Abu-Rustum NR, Zhou Q, Iasonos A, Alektiar KM, et al. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer. 2010;21:511–6.CrossRef
11.
Zurück zum Zitat Gregory PA, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1. Nat Cell Biol. 2008;10:593–601.PubMedCrossRef Gregory PA, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1. Nat Cell Biol. 2008;10:593–601.PubMedCrossRef
12.
Zurück zum Zitat Kim BH, Hong SW, Kim A, Choi SH, Yoon SO. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol. 2012. doi:10.1002/jso.23271. Kim BH, Hong SW, Kim A, Choi SH, Yoon SO. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol. 2012. doi:10.​1002/​jso.​23271.
13.
Zurück zum Zitat Ferraz C, Lorenz S, Wojtas B, Bornstein SR, Paschke R, Eszlinger M. Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis. J Clin Endocrinol Metab. 2013; 98(1):E8–E16. Ferraz C, Lorenz S, Wojtas B, Bornstein SR, Paschke R, Eszlinger M. Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis. J Clin Endocrinol Metab. 2013; 98(1):E8–E16.
14.
Zurück zum Zitat Lai KW, Koh KX, Loh M. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer. 2010;46:1456–63.PubMedCrossRef Lai KW, Koh KX, Loh M. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer. 2010;46:1456–63.PubMedCrossRef
15.
Zurück zum Zitat Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39(5):673–7.PubMedCrossRef Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39(5):673–7.PubMedCrossRef
16.
Zurück zum Zitat Karube Y, Tanaka H, Osada H. Reduced expression of DICER1 associated with poor prognosis in lung cancer patients. Cancer Sci. 2005;96:111–5.PubMedCrossRef Karube Y, Tanaka H, Osada H. Reduced expression of DICER1 associated with poor prognosis in lung cancer patients. Cancer Sci. 2005;96:111–5.PubMedCrossRef
17.
Zurück zum Zitat Kawase-Koga Y, Low R, Otaegi G, Pollock A, et al. RNAase-III enzyme DICER1 maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci. 2010;123:586–94.PubMedCrossRef Kawase-Koga Y, Low R, Otaegi G, Pollock A, et al. RNAase-III enzyme DICER1 maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci. 2010;123:586–94.PubMedCrossRef
18.
Zurück zum Zitat Zhang L, et al. DICER1 ablation impairs prostate stem cell activity and causes prostate atrophy. Stem Cells. 2010;28(7):1260–9.PubMed Zhang L, et al. DICER1 ablation impairs prostate stem cell activity and causes prostate atrophy. Stem Cells. 2010;28(7):1260–9.PubMed
19.
Zurück zum Zitat Suárez Y, Fernandez-Hernando C, Pober JS, Sessa WC. DICER1 dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res. 2007;100:1164–73.PubMedCrossRef Suárez Y, Fernandez-Hernando C, Pober JS, Sessa WC. DICER1 dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res. 2007;100:1164–73.PubMedCrossRef
20.
Zurück zum Zitat Aglund K, Rauvala M, Puistola U, Angstrom T, TurpeenniemiHujanen T, Zackrisson B, Stendahl U. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol. 2004;94:699–704.PubMedCrossRef Aglund K, Rauvala M, Puistola U, Angstrom T, TurpeenniemiHujanen T, Zackrisson B, Stendahl U. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol. 2004;94:699–704.PubMedCrossRef
21.
Zurück zum Zitat Filipowicz W, Bhattacharyya SN, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102–114. Filipowicz W, Bhattacharyya SN, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102–114.
Metadaten
Titel
miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer
verfasst von
Bi-Lan Li
Cong Lu
Wen Lu
Ting-ting Yang
Junjie Qu
Xiayu Hong
Xiao-ping Wan
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 1/2013
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-013-0484-0

Weitere Artikel der Ausgabe 1/2013

Medical Oncology 1/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.